Truist Maintains Exelixis at Hold, Raises Price Target to $60
Truist Securities maintained its Hold rating on Exelixis and raised its price target to $60 from $54.
Truist Securities maintained its Hold rating on Exelixis and raised its price target to $60 from $54.